Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort

被引:5
作者
Barlam, Tamar F. [1 ]
Soria-Saucedo, Rene [2 ,7 ]
Ameli, Omid [3 ]
Cabral, Howard J. [4 ]
Kaplan, Warren A. [5 ]
Kazis, Lewis E. [6 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA
[2] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA
[3] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[5] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA
[6] Boston Univ, Sch Publ Hlth, Hlth Outcomes Unit, Dept Hlth Law Policy & Management, Boston, MA USA
[7] Minist Hlth, Project Strengthen Training Syst Resources Human, La Paz, Bolivia
关键词
IRRITABLE-BOWEL-SYNDROME; INCREASED RISK; OUTCOMES; IMPACT; COSTS; MICROBIOTA; MORTALITY; DISEASE;
D O I
10.1371/journal.pone.0209152
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Elderly patients and those with comorbid conditions are at high risk for poor outcomes after Clostridium difficile infection (CDI) but outcomes in a healthier, nonelderly population are not well described. We sought to investigate gastrointestinal diagnoses and CDI during hospitalizations in the 24 to 36 months after an initial episode of CDI in nonelderly patients in a cohort with an overall low prevalence of comorbid conditions. We performed a retrospective analysis of hospital admissions from 2010-2013 using the Truven MarketScan database of employment-based private insurance claims. Subjects <65 years of age and their adult dependents (> = 18 years old); a CDI diagnosis in 2011 (index date); at least 12 months of pre-index continuous enrollment; and 24-36 months of continuous post-index enrollment were included. The 12 months of each subject's enrollment prior to the index date for a CDI served as the reference period for the analyses of that subject's post-CDI time periods. Hospital claims during the follow-up period were evaluated for gastrointestinal diagnoses and/or CDI ICD-9 codes. The risk of gastrointestinal diagnoses was assessed using Cox proportional hazards models adjusted for a pre-specified set of baseline demographic and clinical factors. During 2011, 5,632 subjects with CDI met the inclusion criteria for our study. The risk of gastrointestinal diagnoses in patients with a CDI diagnostic code for the same admission was almost 8-fold higher 3 months post-CDI (hazard ratio (HR) = 7.56; 95% confidence interval (CI): 2.97-19.19) than for subjects without CDI and remained statistically significant until month 24 (HR = 1.47; 95% CI = 1.04-2.08). After CDI, patients remained at risk for gastrointestinal symptoms with CDI for up to two years. There is an important, long-term health-care burden after CDI in this population.
引用
收藏
页数:12
相关论文
共 39 条
[11]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[12]   Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study [J].
Doh, Young Seok ;
Kim, You Sun ;
Jung, Hye Jin ;
Park, Young Il ;
Mo, Jin Won ;
Sung, Hyun ;
Lee, Kyung Jin ;
Seo, Young Ki ;
Moon, Jeong Seop ;
Hong, Seong Woo .
INTESTINAL RESEARCH, 2014, 12 (04) :299-305
[13]   ICD-9 codes and surveillance for Clostridium difficile-associated disease [J].
Dubberke, Erik R. ;
Reske, Kimberly A. ;
McDonald, L. Clifford ;
Fraser, Victoria J. .
EMERGING INFECTIOUS DISEASES, 2006, 12 (10) :1576-1579
[14]   Attributable Inpatient Costs of Recurrent Clostridium difficile Infections [J].
Dubberke, Erik R. ;
Schaefer, Eric ;
Reske, Kimberly A. ;
Zilberberg, Marya ;
Hollenbeak, Christopher S. ;
Olsen, Margaret A. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (11) :1400-1407
[15]   The intestinal microbiota and chronic disorders of the gut [J].
DuPont, Andrew W. ;
DuPont, Herbert L. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (09) :523-531
[16]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[17]   Increased Risk of Functional Gastrointestinal Sequelae After Clostridium difficile Infection Among Active Duty United States Military Personnel (1998-2010) [J].
Gutierrez, Ramiro L. ;
Riddle, Mark S. ;
Porter, Chad K. .
GASTROENTEROLOGY, 2015, 149 (06) :1408-1414
[18]   All-Cause and Disease-Specific Mortality in Hospitalized Patients With Clostridium difficile Infection: A Multicenter Cohort Study [J].
Hensgens, Marjolein P. M. ;
Goorhuis, Abraham ;
Dekkers, Olaf M. ;
van Benthem, Birgit H. B. ;
Kuijper, Ed J. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (08) :1108-1116
[19]   Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics [J].
Hensgens, Marjolein P. M. ;
Goorhuis, Abraham ;
Dekkers, Olaf M. ;
Kuijper, Ed J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (03) :742-748
[20]   A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection [J].
Jackson, Melissa ;
Olefson, Sidney ;
Machan, Jason T. ;
Kelly, Colleen R. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (09) :742-746